Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.91 - $7.32 $2,183 - $8,366
-1,143 Reduced 31.02%
2,542 $7,000
Q4 2023

Feb 13, 2024

SELL
$4.84 - $8.44 $6,074 - $10,592
-1,255 Reduced 25.4%
3,685 $27,000
Q3 2023

Nov 14, 2023

SELL
$7.21 - $10.68 $13,021 - $19,288
-1,806 Reduced 26.77%
4,940 $37,000
Q2 2023

Aug 21, 2023

BUY
$6.49 - $13.36 $43,781 - $90,126
6,746 New
6,746 $68,000
Q2 2022

Aug 15, 2022

SELL
$3.89 - $7.81 $31,602 - $63,448
-8,124 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$6.47 - $16.99 $23,654 - $62,115
3,656 Added 81.83%
8,124 $53,000
Q3 2021

Nov 15, 2021

BUY
$17.0 - $32.84 $75,956 - $146,729
4,468 New
4,468 $119,000

Others Institutions Holding IMRX

About Immuneering Corp


  • Ticker IMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,392,300
  • Market Cap $57.8M
  • Description
  • Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...
More about IMRX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.